2024
Disparities in race, ethnicity, sex, and age inclusion in pancreatic cancer screening studies: a systematic review and meta-analysis
Silva-Santisteban A, Hernandez Woodbine M, Noriega M, Rabinowitz L, Grimshaw A, Farrell J, Chhoda A, Sawhney M. Disparities in race, ethnicity, sex, and age inclusion in pancreatic cancer screening studies: a systematic review and meta-analysis. Gastrointestinal Endoscopy 2024, 100: 1-16.e20. PMID: 38432492, DOI: 10.1016/j.gie.2024.02.014.Peer-Reviewed Original ResearchCancer screening studyPopulation-based benchmarksPancreatic cancer screeningProportion of study participantsScreening studiesPancreatic cancer outcomesAge reportingInclusion of participantsMedian participant ageCancer screeningCancer outcomesStudy qualityWeb of Science Core CollectionNon-LatinoStudy participantsParticipant agePancreatic cancer studiesYear of publicationOvid MEDLINEGeneral populationSystematic reviewMeta-regressionSystematic searchScience Core CollectionOvid Embase
2023
The global prevalence of human fascioliasis: a systematic review and meta-analysis
Infantes L, Yataco G, Ortiz-Martínez Y, Mayer T, Terashima A, Franco-Paredes C, Gonzalez-Diaz E, Rodriguez-Morales A, Bonilla-Aldana D, Barahona L, Grimshaw A, Chastain D, Sillau S, Marcos L, Henao-Martínez A. The global prevalence of human fascioliasis: a systematic review and meta-analysis. Therapeutic Advances In Infectious Disease 2023, 10: 20499361231185413. PMID: 37434654, PMCID: PMC10331341, DOI: 10.1177/20499361231185413.Peer-Reviewed Original ResearchHuman fascioliasisHigh prevalenceGlobal prevalenceSystematic reviewTropical diseasesLarger study sample sizeFollowing inclusion criteriaRandom-effects modelAppropriate diagnostic methodologyHigher prevalence estimatesWorld Health OrganizationRetrospective cohortCase seriesPooled prevalenceSignificant morbiditySubgroup analysisDisease burdenPrevalence proportionsClinical trialsJBI SUMARIWorldwide prevalenceStudy sample sizeInclusion criteriaMethodological qualityGeneral population
2022
SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis
Conway R, Grimshaw AA, Konig MF, Putman M, Duarte‐García A, Tseng LY, Cabrera DM, Chock YPE, Degirmenci HB, Duff E, Egeli BH, Graef ER, Gupta A, Harkins P, Hoyer BF, Jayatilleke A, Jin S, Kasia C, Khilnani A, Kilian A, Kim AHJ, Lin CMA, Low C, Proulx L, Sattui SE, Singh N, Sparks JA, Tam H, Ugarte‐Gil M, Ung N, Wang K, Wise LM, Yang Z, Young KJ, Liew JW, Grainger R, Wallace ZS, Hsieh E, Alliance T. SARS–CoV‐2 Infection and COVID‐19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta‐Analysis. Arthritis & Rheumatology 2022, 74: 766-775. PMID: 34807517, PMCID: PMC9011807, DOI: 10.1002/art.42030.Peer-Reviewed Original ResearchConceptsSARS-CoV-2 infectionMechanical ventilationRisk ratioOdds ratioMortality rateCOVID-19 disease severityJoanna Briggs Institute critical appraisal toolsCOVID-19Odds of hospitalizationNewcastle-Ottawa ScaleCOVID-19 outcomesRandom-effects modelCritical appraisal toolMantel-Haenszel formulaSystematic literature reviewAdjusted riskICU admissionRMD patientsClinical outcomesRheumatic diseasesMethodologic qualityRelative riskObservational studyGeneral populationLower risk